1 |
Coenraads PJ. Hand eczema. N Engl J Med. 2012;367(19):1829-37.
DOI
|
2 |
Wollina U. Pompholyx: what's new? Expert Opin Investig Drugs. 2008;17(6):897-904.
DOI
|
3 |
Soler DC, Bai X, Ortega L, Pethukova T, Nedorost ST, Popkin DL, et al. The key role of aquaporin 3 and aquaporin 10 in the pathogenesis of pompholyx. Med Hypotheses. 2015;84(5):498-503.
DOI
|
4 |
Mohamed Abd El-Aziz T, Garcia Soares A, Stockand JD. Snake venoms in drug discovery: valuable therapeutic tools for life saving. Toxins (Basel). 2019;11(10):564.
DOI
|
5 |
Song SY, Bae K, Shin KH, Yoo HS. A case series of snake venom pharmacopuncture for chemotherapy-induced peripheral neuropathy: a retrospective observational study. J Pharmacopunct. 2017;20(4):280-6.
DOI
|
6 |
Lee JS, Kwon GR. The study on the snake venom. J Pharmacopunct. 1999;2(1):73-91.
DOI
|
7 |
Plachouri KM, Georgiou S. Mesotherapy: safety profile and management of complications. J Cosmet Dermatol. 2019;18(6): 1601-5.
DOI
|
8 |
Lee JC, Daniels MA, Roth MZ. Mesotherapy, microneedling, and chemical peels. Clin Plast Surg. 2016;43(3):583-95.
DOI
|
9 |
Gill J, Pratt M. A severe case of recalcitrant pompholyx. J Cutan Med Surg. 2015;19(5):494-7.
DOI
|
10 |
Schwarz T. No eczema without keratinocyte death. J Clin Invest. 2000;106(1):9-10.
DOI
|
11 |
Wollina U. Pompholyx: a review of clinical features, differential diagnosis, and management. Am J Clin Dermatol. 2010;11(5): 305-14.
DOI
|